Tarrytown-headquartered Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is collaborating with Celularity Inc. (NASDAQ:CELU) a Florham Park, New Jersey-based biotechnology company, in a multi-year agreement focused on allogeneic cell therapy candidates.
Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Celularity (CELU) Announces Multi-Year Research Collaboration Services Agreement With Regeneron streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Celularity Inc (NASDAQ: CELU) shares are trading higher after the company announced a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals Inc (NASDAQ: REGN).